Bundesverband Medizinischer Auftragsinstitute (bvma) E.v.

What Bundesverband Medizinischer Auftragsinstitute (bvma) E.v. does

BVMA (Bundesverband Medizinischer Auftragsinstitute e.V.) is a Munich-based registered association (eingetragener Verein) founded in July 1991 that serves as the representative body for German-speaking Contract Research Organizations (CROs) active in clinical research. As of June 2026, the association has 52 member companies plus one honorary member, collectively employing approximately 8,000 people and representing more than 80% of employees in the German CRO market. Member companies include global players such as IQVIA RDS GmbH and specialized firms such as FGK Clinical Research GmbH and FutureMeds GmbH; board members lead these organizations directly.

The association's core deliverables are membership services and member-only programs rather than commercial products. Its offering includes a three-yearly mandatory system audit program that functions as a self-imposed quality certification, internal continuing education on topics such as GCP, pharmacovigilance, CDISC, and project management, an annual scientific symposium (the 34th edition scheduled for November 20, 2026 at Holiday Inn Munich - City Centre), standardized model contract clauses for clinical trial negotiations, a job portal, and policy advocacy in German and European regulatory bodies. BVMA is a founding member of EUCROF (European CRO Federation, established October 2005) and participates in the Verbändeplattform alongside DHM, KKSN, vfa, BPI, Pharma Deutschland, and BVMed.

BVMA's revenue model is anchored in membership fees and symposium registrations, with the 2026 symposium priced at €650 per member attendee, €790 per non-member, and €290 per young professional (born 1996 or later). Additional revenue is generated through training events and associate sponsorship. The association employs between 11 and 50 staff, maintains offices at Heimeranstrasse 35 c/o FGK GmbH in Munich, and does not publicly disclose financials. Distribution and acquisition of new members run through a formal application process requiring minimum two years of commercial operation, a successful system audit, and two references from existing members.

Name

Bundesverband Medizinischer Auftragsinstitute (bvma) E.v.

Legal name

Bundesverband Medizinischer Auftragsinstitute e.V.

Website

https://bvma.de

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

BVMA (Bundesverband Medizinischer Auftragsinstitute e.V.) is a Munich-based trade association founded in 1991 that represents 52 German-speaking Contract Research Organizations, covering more than 80% of the German CRO market, through membership services, quality audits, training, and policy advocacy.

Ownership category

akta.pro rank

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Pricing tiers

Distribution channels1 record

Marketing channels5 records

Core offering

Bundesverband Medizinischer Auftragsinstitute (BVMA) is a registered non-profit trade association (e.V.) founded in 1991 in Munich that represents German-speaking Contract Research Organisations (CROs) active in clinical research. It provides membership-based services including industry advocacy and regulatory representation, a self-imposed quality assurance and audit program for member CROs, internal continuing education and training, an annual scientific symposium, standardized clinical trial contract templates, and a job portal for member firms.

Product overview

The BVMA is a professional association representing German-speaking Contract Research Organizations (CROs), not a product company. It offers membership-based services including an annual scientific symposium, internal continuing education (training on topics such as Clinical Trial Directives, GCP, pharmacovigilance, CDISC, project management, and legal/contractual matters), a self-imposed quality assurance/audit program for members, standard contract template libraries for clinical trials (Mustervertragsklauseln), a job portal for member firms, and representation/policy advocacy on behalf of member CROs in German and European regulatory bodies. The association also hosts video content and maintains a link directory of relevant regulatory and industry resources. No proprietary software product is sold by the BVMA.

Differentiator

Problem solved

Functional benefit

Products and services

• Annual BVMA Symposium Annual scientific and networking symposium for member CROs, industry stakeholders, and clinical research professionals, attracting nearly 300 participants annually with presentations, roundtables, and networking opportunities on current industry topics.
• BVMA Internal Continuing Education and Training Program Continuing education training program for BVMA member CRO staff covering clinical trial directives, contracts, risk management, pharmacovigilance, GCP/GMP interface, CDISC, and project management topics.
• BVMA Quality Standard and Audit Program Mandatory triennial system audit and quality certification program for member CROs, intended to assure quality standards across the German CRO industry.
• Standard Contract Templates (Mustervertragsklauseln 2.0) Standardised model contract clauses (Mustervertragsklauseln 2.0) for clinical trial negotiations between sponsors, study centres, and CROs, designed to accelerate clinical trial start-up and standardise contract terms across the German research location.
• BVMA Membership Program Membership program for Contract Research Organisations providing regulatory representation, quality certification, training access, networking, special insurance rates (professional liability, D&O, cyber), and access to the annual symposium at member rates.
• BVMA Job Portal Online job portal hosted by BVMA enabling member CRO firms to advertise clinical research positions and candidates to access CRO employment opportunities.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• EUCROF (European CRO Federation)coreStrategic or Co-development Partner · 1 October 2005BVMA is a founding member of EUCROF, the European CRO umbrella organization founded in October 2005 in the Netherlands. The secretariat is currently located in Rome. EUCROF represents CRO associations from Belgium, Germany (BVMA), France, Greece, Italy, Netherlands, Spain, Czech Republic, UK, Lithuania, Sweden, Romania, and Slovakia, plus 20+ associate members from other countries. The federation represents over 300 CROs with more than 20,000 employees.
• Verbändeplattform (Association Platform)coreStrategic or Co-development PartnerBVMA collaborates with Deutsche Hochschulmedizin (DHM), KKS-Netzwerk (KKSN), Verband der forschenden Pharma-Unternehmen (vfa), Bundesverband der Pharmazeutischen Industrie (BPI), Pharma Deutschland, and Bundesverband Medizintechnologie (BVMed) in the 'Verbändeplattform'. This coalition develops standardized contract templates for clinical trials to simplify contract negotiations and strengthen Germany as a research location.
• STUDIEN WIRKEN InitiativeminorGTM or Marketing PartnerBVMA supports the STUDIEN WIRKEN initiative which aims to raise awareness about clinical trials and their importance. Martin Krauss, BVMA's Vorstandsvorsitzender (Chairman), serves on the Advisory Board of this initiative.
• ACRO (USA)minorStrategic or Co-development PartnerEUCROF maintains intercontinental relations with ACRO in the USA and JCROA in Japan, including the Tokyo Declaration.
• JCROA (Japan)minorStrategic or Co-development PartnerEUCROF maintains intercontinental relations with JCROA in Japan and ACRO in the USA, including the Tokyo Declaration.

Scale indicators4 records

Recent moves2 records

Expansion highlights4 records

Broad incumbents

• vfa (Verband der forschenden Pharma-Unternehmen): vfa is the German association of research-based pharmaceutical companies. It is a partner organization within the Verbändeplattform that BVMA co-leads on contract standardization, and represents the sponsor side of the same clinical trials ecosystem in which BVMA member CROs operate.
• BVMed (Bundesverband Medizintechnologie): BVMed is the German medical technology industry association. It is a co-developer of the Mustervertragsklauseln alongside BVMA and represents adjacent device-industry stakeholders in the same clinical research regulatory landscape.
• Deutsche Hochschulmedizin (DHM): DHM is the German academic medicine association coordinating university medical centers. It is a Verbändeplattform partner with BVMA and shares the academic clinical trial infrastructure agenda, making it an institutional peer in the same regulatory advocacy space.
• BPI (Bundesverband der Pharmazeutischen Industrie): BPI is the German pharmaceutical industry association. It is a Verbändeplattform co-signatory of the Standard Contract Clauses with BVMA and serves a broader pharma membership that includes many of the same sponsors using BVMA member CROs.

Direct peers

• ACRO (Association of Clinical Research Organizations): ACRO is the US counterpart trade association for CROs and is formally linked to BVMA via EUCROF through the Tokyo Declaration. It represents the same member type (contract research organizations) in a different regulatory jurisdiction, making it a clear structural peer.
• KKS-Netzwerk (KKSN): KKS-Netzwerk is the German network of Coordinating Centers for Clinical Trials at academic medical centers. It co-developed the Verbändeplattform contract templates alongside BVMA and serves an overlapping stakeholder community (clinical trial operators in Germany), making it a close functional peer.
• EUCROF (European CRO Federation): EUCROF is the pan-European CRO federation of which BVMA is a founding member. It directly represents the same CRO constituency at the European level, offering BVMA both a coordination partner and a potential substitute/competitor for international sponsor engagement.

Regional players

• AFCROs (Association Française des CROs): AFCROs is the French member association of EUCROF representing French-speaking CROs. It is the direct national-level peer to BVMA in a neighboring EUCROF member country, with a comparable membership-and-quality-certification model.
• JCROA (Japan CRO Association): JCROA is Japan's CRO trade association and the third signatory of EUCROF's Tokyo Declaration alongside ACRO. It is functionally identical to BVMA — a national CRO trade association — but serves a different geography and is therefore a regional peer rather than a direct competitor.

Emerging players

• SCRS (Society for Clinical Research Sites): SCRS is a global not-for-profit representing clinical research sites (the customer side that BVMA member CROs serve). While not a CRO association, it is a structurally similar trade body operating in the same clinical research ecosystem with overlapping membership at the trial-operator level.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bvma-germany

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bundesverband Medizinischer Auftragsinstitute (bvma) E.v.